CGT

116개 · ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-5 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved116 programs
CGTLimited DatastaleShanghai Unicar-Therapy Bio-med…Phase 1

Triple-targeted CAR-T Therapy (Triple-targeted CAR-T Therapy)

B-cell Lymphoma · B-cell Lymphoma

#B-cellLymphoma#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Discontinued
CGTLimited DatastaleShanghai Unicar-Therapy Bio-med…Phase 2

U32 CAR-T (U32 CAR-T)

Acute Myeloid Leukaemia · Acute Myeloid Leukaemia

#AcuteMyeloidLeukaemia#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 1Status Recruiting
CGTLimited DatastaleShanghai Unicar-Therapy Bio-med…Phase 1

U87 CAR-T (U87 CAR-T)

Pancreatic Cancer; Solid Tumor, Adult · Pancreatic Cancer

#PancreaticCancer#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Active
CGTLimited DatastaleNew Approaches to Neuroblastoma…Phase 2

Universal Donor (UD, Universal Donor, Universal Donor (UD) TGFβi NK Cells)

Neuroblastoma · Neuroblastoma

#Neuroblastoma#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 1Status Recruiting
CGTLimited DatastaleBeijing 302 HospitalPhase 2

allogeneic NK cells therapy (allogeneic NK cells therapy)

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 1Status Active
CGTLimited DatastaleThe Children's Hospital of Zhej…Phase 1

anti-BCMA/CD70-CAR-T cells (anti-BCMA/CD70-CAR-T cells)

CAR T Cell Therapy; Systemic Lupus Erythematosus · BCMA

#BCMA#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleChinese PLA General HospitalPhase 2

anti-CD33 CART (anti-CD33 CART)

Relapsed Adult Myeloid Leukemia; Chemotherapy Refractory Adult Myeloid Leukemia · CD33

#CD33#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Active
CGTLimited DatastaleShanghai Cell Therapy Research …Phase 2

anti-CTLA-4/PD-1 expressing EGFR-CAR-T (anti-CTLA-4/PD-1 expressing EGFR-CAR-T)

Advanced Solid Tumor · EGFR

#EGFR#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTLimited DatastaleBeijing GoBroad HospitalPhase 1

autologous FL-33 CAR T therapy (autologous FL-33 CAR T therapy)

Refractory/Relapsed Acute Myeloid Leukaemia · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleYuLiPhase 2

dual target CAR-T cell therapy (dual target CAR-T cell therapy)

Lymphoma, B-Cell; Relapse/Recurrence · FRα

#FR#CGT#Phase2#cell-gene-therapy#CAR-T+5
Trials 1Status Active
CGTLimited DatastaleShanghai iCELL Biotechnology Co…Phase 1

haploid allogeneic NK cell therapy (haploid allogeneic NK cell therapy)

Acute Myeloid Leukemia · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Active
CGTLimited DatastaleUNC Lineberger Comprehensive Ca…Phase 1

iC9-CAR.B7-H3 T Cell Therapy (iC9-CAR.B7-H3 T Cell Therapy)

Breast Cancer; Relapse · B7-H3

#B7-H3#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleUniversity of PennsylvaniaPreclinical

lentiviral-based CART meso therapy (lentiviral-based CART meso therapy)

Subjects Who Have Received Lentiviral-based CART-meso Therapy · Multi-target

#Multi-target#CGT#Preclinical#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTLimited DatastaleEunice Kennedy Shriver National…Phase 2

lymphocyte gene therapy (lymphocyte gene therapy)

Mucopolysaccharidosis II · Mucopolysaccharidosis II

#MucopolysaccharidosisII#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 1Status Active
CGTLimited DatastaleShenzhen SiBiono GeneTech Co.,L…Approved

p53 gene therapy (p53 gene therapy)

Advanced Malignant Thyroid Tumors · Advanced Malignant Thyroid Tumors

#AdvancedMalignantThyroidTumors#CGT#Approved#cell-gene-therapy#CAR-T+2
Trials 1Status Active
CGTLimited DatastaleBeijing GoBroad HospitalPhase 1

prior-HSCT donor-derived FL-33 CAR T therapy (prior-HSCT donor-derived FL-33 CAR T therapy)

Refractory/Relapsed Acute Myeloid Leukaemia · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting

6 / 6 pages

← PreviousNext →